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Secondary structureCell-penetrating peptides (CPPs) and antimicrobial peptides (AMPs) show great potential as drug delivery
vectors and new antibiotic drug entities, respectively. The current study deals with the properties of a variety
of peptide analogs derived from the well-known CPP penetratin as well as octaarginine and different Tat se-
quences. The effects of peptide length, guanidinium content, and sequence of non-cationic residues were
assessed in mammalian and bacterial cells. The arginine (Arg) content in the penetratin analogs was found
to inﬂuence eukaryotic cell uptake efﬁciency, antimicrobial activity towards both Gram-positive and
Gram-negative bacteria as well as eukaryotic cell viability. All examined analogs retained the ability to
cross eukaryotic membranes giving rise to a distribution within the vacuolar apparatus. Interestingly, a series
of shufﬂed analogs of penetratin with the cationic residues in conserved positions, attain the same α-helical
conformation as native penetratin in the presence of cholesterol-containing liposomes, while conformational
differences were observed in the presence of highly anionic liposomes. While the antibacterial effect of the
two groups of peptides was similar, the eukaryotic cellular uptake of the shufﬂed analogs was noticeably
lower than for native penetratin. Moreover, a point substitution of Met to Leu in native penetratin had no in-
ﬂuence on eukaryotic cellular uptake and antimicrobial effect, and only a minor effect on cytotoxicity, in con-
trast to the fact that the same substitution in the shufﬂed analog gave rise to reduced eukaryotic cellular
uptake while increasing the antibacterial effect and cytotoxicity.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Conventionally, short cationic membrane-interacting peptides
have been classiﬁed according to their effect originally found, thus
cell-penetrating peptides (CPPs) [1] and antimicrobial peptides
(AMPs) [2] are considered classes of potential non-therapeutic
excipients and potential antibiotics, respectively. Structurally, CPPs
and AMPs share the common features of being relatively short
peptides (10–40 residues) with a positive net charge that facilitates
interaction with negatively charged phospholipid membranes [3].
The nature of the primary sequence of both CPPs and AMPs appears
to be of great signiﬁcance for the activity, as a high content of cationic
amino acids is a prerequisite for their initial association with nega-
tively charged membrane components [4–7]. The ratio between thecarboxyﬂuorescein; CF, 5(6)-
dium; FBS, fetal bovine serum;
hyl)-1-piperazineethanesulfonic
concentration; PBS, phosphate
oyl-oleoyl phosphatidylcholine;
c index
45 3533 6030.
lsen).
rights reserved.cationic lysine (Lys) and arginine (Arg) residues inﬂuences mem-
brane selectivity since the guanidino functionalities of arginines
promote a more efﬁcient interaction with eukaryotic membranes as
compared to lysine. This is, however, most often at the expense of
increased cytotoxicity. A high Lys content has been correlated with
selectivity towards bacterial cells over eukaryotic cells [8]. Further-
more, the ability of CPPs to permeate cell membranes appears to be
directly linked to their propensity to fold into a well-deﬁned second-
ary structure (α-helix or β-sheet) while interacting with biological
membranes [9,10]. Likewise, the antimicrobial activity of α-helical
AMPs depends on their propensity to form an α-helix [11–13].
The exact internalization mechanisms for CPPs are persistently
debated, however, there seems to be consensus of the fact that
more than one mechanism may be involved. Several endocytotic
pathways as well as direct transduction have been documented.
Nevertheless, the distinction between pathways as well as the pres-
ence of other contributing mechanisms are still unresolved [14,15].
Recent studies have revived direct translocation of CPPs as a possible
transport mechanism, in particular at lower CPP concentrations [16].
One hypothesis states that the initial step in peptide-membrane
interactions is induction of a higher degree of folding into a secondary
structure (e.g. an α-helical conformation). While surface-bound, the
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process seem to determine the actual uptake mechanism [17].
Furthermore, the chemical and enzymatic stability of CPPs against
extracellular degradation is of importance for successful internaliza-
tion, while intracellular stability is a prerequisite for further trafﬁck-
ing within the target cell [18]. Besides, the uptake process and
kinetics both depend on the speciﬁc target cell, temperature the
transported cargo, and the CPP concentration [19]. The composition
and character of the phospholipid membrane are considered key
factors in determining the selectivity of membrane-interacting
peptides [20,21].
Bacterial membranes are generally more negatively charged than
mammalian cell membranes due to their higher content of anionic
phospholipids as well as LTA (lipoteichoic acid) or LPS (lipopolysac-
charide) for Gram-positive and Gram-negative bacteria, respectively
[22]. By contrast, zwitterionic phospholipids and cholesterol are the
main constituents of mammalian cell membranes. Moreover, the
asymmetric distribution of these phospholipids, along with other
membrane components, between the inner and outer leaﬂets of the
bacterial and mammalian cells, further contributes to AMP selectivity
[23].
Increasing evidence indicates that membrane-interacting peptides
in factmay exhibit cross-functionality, e.g. some AMPs possess the abil-
ity to cross mammalian cell membranes by non-damaging processes,
while several CPPs display signiﬁcant antimicrobial activity. For exam-
ple, Tat48–60 from the HIV-1 transactivating protein has been shown to
inhibit growth of both Gram-positive and Gram-negative bacteria as
well as of fungi [24,25]. Similarly, Pep-1 derived from simian virus,
has been modiﬁed (Glu→Lys) into an antimicrobial analog, Pep-1-K
that possesses activity towards Gram-positive and Gram-negative bac-
teria [26,27]. Also, pVEC derived fromcadherin exhibits activity towards
both Gram-negative and Gram-positive bacteria [28,29], while TP10, a
deletion analog of the chimeric CPP transportan, possesses potency
against Gram-positive bacteria and fungi [29]. Furthermore, the
designed model amphipathic peptide (MAP) shows antibacterial activ-
ity, whereas it does not exhibit antifungal activity [28]. For an extensive
review see Splith and Neundorf [30].
The 16-mer penetratin (RQIKIWFQNRRMKWKK) originating from
the third helix of the Antennapedia homeodomain [31] has been
known for almost two decades, and it is still being extensively
examined. Substantial efforts have been directed towards the under-
standing of its mechanism of translocation across mammalian cell
membranes. This includes several attempts at modifying the native
penetratin sequence by single-residue substitutions [32,33] as well
as replacement of multiple amino acids [34,35] both to uncover the
mechanism of uptake and to ﬁne-tune efﬁciency. An antimicrobial
effect has been demonstrated for penetratin and a few analogs
derived from this CPP. Thus, activity against both Gram-positive
[28,36,37] and Gram-negative [36] bacteria has been reported for na-
tive penetratin. Several analogs of penetratin have been investigated
with the aim of gaining a further understanding of the structural
requirements for potentially enhancing cell-penetrating activity.
This comprise interchange of cationic residues [9,34,38–40], trunca-
tion [33,41], shufﬂing of amino acid residues [40,41], as well as
dimerization of the native peptide [36]. Additionally, both native
penetratin and several analogs have been shown to possess antifun-
gal properties [41,42].
The ability of some bacterial species to internalize into the intra-
cellular compartment of mammalian cells and thereby separating
themselves from chemotherapeutic treatment as well as host im-
mune defense may lead to persistent or recurrent infections due
to inefﬁcient intracellular killing of the bacteria [43,44]. A range of
bacteria commonly utilize this strategy including Mycobacterium
tuberculosis [45], Salmonella enterica [46], Listeria monocytogenes [47]
and Staphylococcus aureus [48]. Peptides capable of both internaliza-
tion into mammalian cells and killing of bacterial pathogens mightwell constitute potential candidates for establishing a novel treat-
ment modality for intracellular infections. Thus, the present work
describes studies of cellular uptake in eukaryotic cells along with
antimicrobial activity of several novel as well as previously reported
penetratin analogs.
2. Materials and methods
2.1. Materials
CF-Tat47–57 was acquired fromNMI Proteins (Reutlingen, Germany).
Rink amide resin and coupling reagents for solid-phase peptide synthe-
siswere acquired from Fluka (Buchs, Switzerland). All amino acid build-
ing blocks as well as other solvents and chemicals for synthesis were
purchased from Iris Biotech (Merktredwitz, Germany). All other mate-
rials were obtained from Sigma-Aldrich (Buchs, Switzerland) unless
stated otherwise.
2.2. Peptide synthesis and labeling
Synthesis of all peptides was carried out by Fmoc-based solid-phase
peptide synthesis (SPPS) by using aMW-assisted automated CEM Liberty
synthesizer (CEM, Matthews, NC, US). All peptides were prepared as
non-labeled and carboxyﬂuorescein (CF)-labeled variants. Upon assem-
bly of the peptide sequence, N-terminal labeling with the ﬂuorophore
was performed with a mixture of 5(6)-carboxyﬂuorescein (2.5
equivalents), diisopropylcarbodiimide (DIC; 2.5 equivalents), and
1-hydroxybenzotriazole (HOBt; 2.5 equivalents) in dimethyl-
formamide (DMF) overnight at room temperature in a teﬂon reac-
tor (10 mL) equipped with a polypropylene ﬁlter. Peptides were
puriﬁed to homogeneity by preparative HPLC (250×20 mm
Phenomenex C18(2) column, 5 μm). A linear gradient of eluent B
(H2O-MeCN 5:95 with 0.1% TFA) in eluent A (H2O-MeCN 95:5
with 0.1% TFA) rising from 0% to 45% over 25 min was applied.
Purity was obtained by analytical RP-HPLC220 nm 0% to 60% over
30 min (>95% purity) and identity by LC–MS using a triple
quadropole MS detector. The peptides were freeze-dried and
stored at −18 °C until further use. An overview of the synthesis
products can be found in Table 1.
2.3. Cell culture
HeLa WT cells from American Type Culture Collection (ATCC)
were maintained in Eagle's minimal essential medium (EMEM)
supplemented with 100 U/mL penicillin, 100 μg/mL streptomycin,
2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mM sodium
pyruvate, and 10% (v/v) fetal bovine serum (FBS) (Fisher Scientiﬁc,
Slangerup, Denmark). Cells were grown in 5% CO2/95% O2, 37 °C
and were detached from culturing ﬂasks at 80% conﬂuency by
trypsin-EDTA treatment, and subcultured at a ratio of approximately
1:5 twice a week.
2.4. MTS/PMS viability assay
The peptide inﬂuence on the cell viability was estimated by using
the MTS/PMS assay [49]. HeLa WT cells were cultured in ﬂat-
bottomed 96-well MicroWell™ Plates (NUNC, Roskilde, Denmark) at
a seeding density of ~30,000 cells/cm2. A subconﬂuent monolayer
(conﬂuence 80–90%) was achieved after 22–24 h of cultivation and
the cells were subsequently washed twice with Hanks Balanced Salt
Solution (HBSS) (Gibco, Paisley, UK) supplemented with 10% (w/v)
HEPES (AppliChem, Darmstadt, Germany) before exposure to 100 μL
of the peptide test solution (concentration range 1–3000 μM) for
1 h (37 °C, 50 rpm). Culture medium and 0.2% (w/v) SDS were used
as negative (ODneg.ctrl) and positive (ODpos.ctrl) control, respectively.
The test solution was removed by inverting the plate, and
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5-(3-carboxy-phenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS)
(Promega, WI, USA) and 2.4 μg/mL phenazine methosulphate (PMS)
in HBSS (Sigma-Aldrich, Buchs, Switzerland) was applied. The plate
was further incubated until an absorbance of approx. 1 for the untreated
cells (2–4 h). Absorbance was measured on a POLARstar Optima (λ=
492 nm) (GMB Labtech, Offenburg, Germany). The relative viability
(%) was calculated according to Eq. (1):
Viability %ð Þ ¼ ODpeptide:–ODpos:ctrl:
 
= ODneg:ctrl:–ODpos:ctrl:
 
: ð1Þ
2.5. Hemolysis
The hemolytic activity of the peptides was tested as described
previously [50]. Human blood was freshly drawn and anticoagulated
by heparin. The red blood cells (hRBC) were collected by centrifuga-
tion and repeatedly washed in TBS (10 mM Tris, 150 mM NaCl; pH
7.2) until the appearance of a clear supernatant. Finally, the hRBCs
were dissolved in TBS to a ﬁnal concentration of 1% (v/v). Two-fold
serial dilutions of the peptides were prepared in Milli-Q water in
96-well plates to a ﬁnal volume of 20 μL. Subsequently, an aliquot
(80 μL) of the 1% (v/v) hRBC suspension was added to each well
obtaining a ﬁnal peptide concentration range of 1–128 μM. After 1 h
(37 °C) of incubation, the plates were centrifuged and an aliquot of
80 μL of the supernatant was transferred to a new plate and diluted
1:1 with Milli-Q water. The absorbance of hemoglobin in the superna-
tant was detected using an Elx 808 Absorbance Microplate Reader
(λ=405 nm) (Bio-Tek Instruments, Winooski, VT, US). The percent-
age of hemolysis was calculated using Eq. (2) where the absorbance
measured from hRBCs incubated with melittin (512 μg/ml) deﬁnesTable 1
Overview of synthesis products.
Abbreviation Sequence
Pen RQIKIWFQNRRMKWKK-NH2
CF-Pen CF-RQIKIWFQNRRMKWKK-NH2
PenLeu RQIKIWFQNRRLKWKK-NH2
CF-PenLeu CF-RQIKIWFQNRRLKWKK-NH2
PenArg RQIRIWFQNRRMRWRR-NH2
CF-PenArg CF-RQIRIWFQNRRMRWRR-NH2
PenLys KQIKIWFQNKKMKWKK-NH2
CF-PenLys CF-KQIKIWFQNKKMKWKK-NH2
Pen10 FQNRRMKWKK-NH2
CF-Pen10 CF-FQNRRMKWKK-NH2
Pen13 KIWFQNRRMKWKK-NH2
CF-Pen13 CF-KIWFQNRRMKWKK-NH2
Pen13Arg RIWFQNRRMRWRR-NH2
CF-Pen13Arg CF-RIWFQNRRMRWRR-NH2
Pen13Lys KIWFQNKKMKWKK-NH2
CF-Pen13Lys CF-KIWFQNKKMKWKK-NH2
PenShuf RWFKIQMQIRRWKNKK-NH2
CF-PenShuf CF-RWFKIQMQIRRWKNKK-NH2
PenShufLeu RWFKIQLQIRRWKNKK-NH2
CF-PenShufLeu CF-RWFKIQLQIRRWKNKK-NH2
PenShufArgLeu RWFRIQLQIRRWRNRR-NH2
CF-PenShufArgLeu CF-RWFRIQLQIRRWRNRR-NH2
PenShufLysLeu KWFKIQLQIKKWKNKK-NH2
CF-PenShufLysLeu CF-KWFKIQLQIKKWKNKK-NH2
W-R8 W-RRRRRRRR-NH2
CF-R8 CF-RRRRRRRR-NH2
W-Tat13 W-GRKKRRQRRRPPQ-NH2
CF-Tat13 CF-GRKKRRQRRRPPQ-NH2
CF-Tat11a CF-YGRKKRRQRRR-NH2
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ-NH2
a Isomer-pure form of (5)-carboxyﬂuorescein was used as ﬂuorophore.100% hemolysis (positive control) and hRBC incubated with TBS
only deﬁnes 0% (negative control):
Hemolysis %ð Þ ¼ ODpeptide–ODneg:ctrl
 
= ODpos:ctrl–ODneg:ctrl
 
: ð2Þ
2.6. Flow cytometry/peptide uptake
Peptide internalization was analyzed by ﬂow cytometry. The
experiment was carried out using HeLa WT cells seeded at a density
of ~210,000 cells/cm2. The cells were grown in 6-well plates
(NUNC, Roskilde, DK) for 48–50 h to a conﬂuence of 80–90%. The
cells were washed with 1 mL PBS (37 °C) and incubated for 1 h
(37 °C, 5% CO2) with 5 μM peptide solution (700 μL; in PBS). Subse-
quently, the cells were rinsed three times with ice-cold PBS. The
cells were detached after exposure to trypsin (200 μL with 0.01%
(w/v) EDTA, 10 min, 37 °C, 5% CO2), and subsequently washed
twice with ice-cold PBS with 10% (w/v) FBS. Finally, the cells were
suspended in 500 μL PBS with 10% (w/v) FBS containing 1 mg/mL
propidium iodide (PI) (Invitrogen, Carlsbad, CA, US). Analysis was
performed shortly after preparation by using a FACScan (Becton Dick-
inson, Franklin Lakes, NJ, US); equipped with a 488 nm argon laser
and a 530/30 nm bandpass ﬁlter for detection. The mean ﬂuorescence
of 10,000 viable cells was acquired with gating based on sideward
and forward scattering as well as on PI ﬂuorescence intensity.
2.7. Confocal laser-scanning microscopy (CLSM)
Visualization of the peptide uptake was carried out on HeLa WT
cells cultured on Poly-D-lysine coated, 35 mm dishes, MatTek Glass
Bottom Microwell Dishes (MatTek, Ashland, MA, US). The seedingDesignation without label Mw
pAntp (43–58) [Penetratin] 2245.74
pAntp (43–58) [Penetratin] 2604.04
pAntp (43–58) (M→L) 2227.35
pAntp (43–58) (M→L) 2585.65
pAntp (43–58) (K→R) 2357.80
pAntp (43–58) (K→R) 2716.10
pAntp (43–58) (R→K) 2161.70
pAntp (43–58) (R→K) 2520.00
pAntp (49–58) 1420.73
pAntp (49–58) 1779.03
pAntp (46–58) 1848.27
pAntp (46–58) 2206.57
pAntp (46–58) (K→R) 1960.32
pAntp (46–58) (K→R) 2318.62
pAntp (46–58) (R→K) 1792.24
pAntp (46–58) (R→K) 2150.54
Shufﬂe2 (R,K ﬁx) 2245.72
Shufﬂe2 (R,K ﬁx) 2604.02
Shufﬂe2 (R,K ﬁx; M→L) 2227.35
Shufﬂe2 (R,K ﬁx; M→L) 2585.65
Shufﬂe2 (R,K ﬁx; K→R; M→L) 2339.76
Shufﬂe2 (R,K ﬁx; K→R; M→L) 2698.06
Shufﬂe2 (R,K ﬁx; R→K; M→L) 2143.66
Shufﬂe2 (R,K ﬁx; R→K; M→L) 2501.96
Octaarginine 1452.73
Octaarginine 1624.82
Tat (48–60) 1904.24
Tat (48–60) 2076.33
Tat (47–57) 1916.06
Melittin 2846.46
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of the experiment, which was after 48–50 h of culturing. The cells
were rinsed with PBS (37 °C), and then incubated for 1 h (37 °C,
50 rpm) with 10 μM peptide solution (300 μL; in PBS) with/without
50 nM Lysotracker® Red (Sigma-Aldrich, Buchs, Switzerland) when
relevant. Subsequently, the test solutions were discarded, the cells
were washed 5 times with ice-cold PBS, and then kept on ice in PBS.
Immediately hereafter, CLSM was performed using an inverted
LSM510 Laser-scanning microscope (Carl Zeiss MicroImaging, Jena,
Germany), with 63× oil immersion objective. Live-cell microscopy
was performed at room temperature.
2.8. Minimal inhibitory concentration (MIC)
The bacterial growth-inhibitory ability of the peptides was
determined by microtiter MIC determination according to CLSI
guidelines [51]. The peptides were tested towards E. coli (ATCC
25922) and S. aureus (ATCC 33591) in triplicate in the concentration
range 2–256 μM. Start inoculum was 5×105 CFU/mL, and incuba-
tion was performed for 16–20 h at 35 °C.
2.9. Preparation of liposomes
Unilamellar liposomes were prepared from palmitoyl–oleoyl phos-
phatidylcholine (POPC) and palmitoyl–oleoyl phosphatidylglycerol
(POPG) in 3:7 molar ratio or POPC, POPG and cholesterol in a 5:3:2
molar ratio. From chloroform solutions of the lipids, the solvent was re-
moved by rotary evaporation. The lipid ﬁlm was stripped with ethanol
three times and dried overnight on a rotary evaporator to remove
trace amounts of chloroform. The lipid ﬁlm was then dispersed in
6 mLof Tris buffer (10 mM, pH7.4) to give empty liposomes for circular
dichroism studies, or HEPES buffer (10 mMHEPES, 150 mMKCl, 1 mM
NaN3, 30 μM CaCl2, 10 μM Na2EDTA; pH 7.4) with 20 mM calcein to
give calcein-containing liposomes for the calcein release studies. The
solutionswere vigorously vortexed six times over 1 h, and the resulting
multilamellar vesicles were extruded once through a 100 nm polycar-
bonate membrane ﬁlter followed by nine extrusions through a
100 nm or 50 nm polycarbonate membrane ﬁlter for empty or
dye-loaded liposomes respectively. The particle size distribution was
measured on a Zetasizer Nano ZS (Malvern, Worcestershire, UK) using
a 633 nm laser and 173° detection optics. Malvern DTS v. 5.10 software
(Malvern, Worcestershire, UK) was used for acquisition and analysis.
2.10. Circular dichroism (CD) spectroscopy
Spectra were measured on an Olis DSM 10 spectrophotometer
(Olis, Bogart, GA, US) using a 0.1 cm quartz cell. The spectra of
peptides were measured at a concentration of 20 μM in 10 mM Tris
buffer in the presence of liposomes using a lipid to peptide ratio of
100:1. All spectra were acquired in the range 195–260 nm and each
spectrum represents an average of 5 scans corrected for background
contributions. All measurements were performed at room temperature.
2.11. Calcein release assay
The assay was performed as earlier described [52,53]. The pep-
tides were diluted to a suitable concentration range in a black
96-well plate (MicroWell 96 optical bottom plates, NUNC, Roskilde,
DK) and calcein containing liposomes were added to a ﬁnal lipid
concentration of 25 μM and a total volume of 180 μL. The samples
were incubated at 37 °C for 1 h and measurements were performed
at regular intervals. The ﬂuorescence of the samples was measured
using a POLARstar Optima plate reader (GMB Labtech, Offenburg,
Germany) at an excitation wavelength of 485 nm and an emission
wavelength of 520 nm.2.12. Statistical analysis
All experiments were performed in triplicate unless otherwise
stated. Results are given as mean±SD, and statistical signiﬁcance
was determined by the students t-test where Pb0.05 is considered
signiﬁcant. The 50% cellular viability (EC50) values were estimated
using GraphPad Prism 5 software through non-linear regression
following Eq. (3):
Y ¼ Bottomþ Top–Bottomð Þ= 1þ X=EC50ð Þ −HillSlopeð Þð Þ: ð3Þ
3. Results
In the present study, 11 analogs of the 16-mer CPP penetratin as
well as native penetratin and three other well-known CPPs were
investigated for their uptake efﬁciency, subcellular localization and
inﬂuence on eukaryotic cell viability along with the ability to inhibit
bacterial growth. Furthermore, model membrane systems were
employed to investigate their secondary structure and ability to
disrupt membrane integrity.
3.1. Eukaryotic cellular uptake
Several studies have ascribed the efﬁcient uptake of penetratin
into eukaryotic cells to the presence of arginine residues [34,39]. To
validate this observation in a quantitative way, the CF-labeled
variants of PenLys and PenArg were applied to HeLa WT cells; the
samples were subsequently analyzed by ﬂow cytometry in order to
determine their propensity for cell penetration. The uptake of native
penetratin was compared to that of the shufﬂed and truncated
analogs of penetratin as well as to that of R8 and Tat.
Under the conditions employed, the series of full-length
penetratin analogs in general exhibited a higher degree of internali-
zation into HeLa WT cells as compared to both truncated and shufﬂed
penetratin analogs (Fig. 1a). Substitution of all Lys residues with Arg
(i.e. PenArg) resulted in an increased uptake as compared to native
penetratin (Pb0.001), whereas substitution of Argwith Lys (i.e. PenLys)
reduced the uptake as expected (Pb0.001) [9,34,39]. By replacing the
single Met residue present in native penetratin, the risk of spontaneous
oxidation was eliminated, and interestingly it was found that the
Leu-containing analog exhibited similar or even slightly increased up-
take as compared to penetratin. This is in agreement with the reported
observations by Fisher et al. [33] that Met12 may be replaced with Leu
without loss of activity.
Truncation of the ﬁrst three N-terminal residues of penetratin
resulted in a 13-mer analog (Pen13) only exhibiting an internaliza-
tion corresponding to approximately half of that of the native peptide,
while the equivalent all-Arg variant (Pen13Arg) retained an uptake of
more than 80% of the level of penetratin. As with the full-length
penetratin analogs, the uptake of Pen13Lys was signiﬁcantly lower
than the level of Pen13 (Pb0.05). Further truncation almost entirely
abolished activity for the 10-mer peptide Pen10 as also found by
Fischer and colleagues [33]. They reported that in HaCaT and A549
cells, the uptake of both Pen13 and Pen10 was approximately 65% rel-
ative to that of native penetratin.
A shufﬂed analog (PenShuf) has earlier been reported to induce
uptake of co-administered insulin over the nasal epithelium [40]. That
effect may in part correspond to increased cellular uptake, though
with our experiments the uptake of the ﬂuorophore-labeled shufﬂed
analogs themselves were lower in comparison with that of the native
penetratin sequence (Pb0.005). The Met→Leu substitution lowered
the uptake of PenShuf. Additional substitutions of Lys→Arg and
Arg→Lys had no effect on the uptake of the ﬂuorophore-labeled
PenShufLeu.
Fig. 1. a) Uptake of CF-labeled peptides into HeLa WT cells as measured by ﬂow cytometry. 10,000 vital cells were gated based on sideward and forward scattering as well as on PI
ﬂuorescence intensity. Results are normalized relative to the CF-Pen signal, and the mean (n=3, n=2 for ♦) is shown with error bars indicating the standard deviation. b) The
histogram shown for selected CF-labeled peptides: CF-Tat13 (yellow), CF-Tat11 (pink), CF-R8 (turquoise), CF-Pen13 (green), CF-PenShuf (blue), and CF-Pen (red).
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the Tat peptide: Tat13 (48–60) and Tat11 (47–57), was compared to
that of penetratin. R8 showed a similar uptake into the HeLa WT cells
as the penetratin analogs, but the histogram (Fig. 1b) showed a much
wider distribution of intensity within the counted cell population.
The same tendency can be seen for the uptake of the shorter Tat11,
while Tat13 gave rise to a more narrow distribution although the
uptake of the Tat peptides was only 13–17% of the uptake of
penetratin. Comparable results have been reported by Jones et al.
[54], where the uptake of rhodamine-labeled penetratin into HeLa
cells were found to exceed the uptake of Tat by approx. 2.5 times.
3.2. Subcellular distribution
The uptake and distribution of CF-labeled penetratin and analogs
as well as of reference peptides were examined in living unﬁxed
HeLa WT cells (Fig. 2). At the conditions employed, all ﬂuorophore-
labeled penetratin analogs gave rise to a punctuated cytosolic distri-
bution (green) showing some co-localization with late lysosomes(yellow). The same pattern was seen for the Tat sequences (data
not shown). CF-R8 yielded a similar punctuated distribution, which
is in accordance with previous reports [55,56]. Both CF(5)-Tat11
and CF-Tat13 showed lower uptake than penetratin with few to
none punctuated vesicles. No co-localization with late lysosomes
was observed for the Tat peptides in accordance with earlier ﬁndings
for their uptake in K562 cells [56].
3.3. Antimicrobial effect and effect on eukaryotic cell viability
The antibacterial activity of the peptides (MIC) was compared to
their inﬂuence on eukaryotic cells (HeLa cell viability and hemolysis
of erythrocytes). Thus, an indicative therapeutic index (TI)was calculat-
ed by relating the cell viability EC50 value to the MIC value (Table 2). A
tendency of higher antibacterial activity against E. coli over S. aureuswas
observed formost of the full-length analogs, whereas this tendencywas
not apparent for the truncated analogs. The shufﬂed analogs showed
similar antimicrobial activity thoughwith a lower eukaryotic cell viabil-
ity as compared to native penetratin. Noticeably, only the shufﬂed
Fig. 2. Confocal images depicting the distribution of 10 μM CF-labeled peptides (green) in live unﬁxed HeLaWT cells incubated with 50 nM late lysosome markers Lysotracker Red®
(red). Incubation for 1 h at 37 °C in atmospheric air. Scale bar 10 µm. (a) CF-Pen, (b) CF-PenArg, (c) CF-PenLys, and (d) CF-PenShuf. Top row depicts the ﬂuorescent peptide and late
lysosome signals as well as light transmission, while the bottom row only depicts the ﬂuorescent signals.
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2–4×MIC. A higher content of Arg clearly enhanced the antibacterial ef-
fect towards both S. aureus (ATCC 33591) and E. coli (ATCC 25922), but
unfortunately at the expense of higher cytotoxicity as indicated by the
effect on cell viability when tested on HeLa WT cells. The shufﬂed ana-
logs were in general equivalent or even superior to penetratin in
inhibiting the growth of E. coli and S. aureus, however, with an unfavor-
able TI due to the concomitantly decreased eukaryotic cell viability. The
inﬂuence of Arg versus Lyswas also evidentwithin the series of shufﬂed
analogs as PenShufArgLeu exhibited increased antimicrobial activity,
but gave rise to a lowered HeLa WT cell viability. Substitution of Met
with Leu in native penetratin reduced the drop in cell viability of HeLa
WT cellswhile retaining the antimicrobial activity. Interestingly, the op-
posite effect was seen for the Met→Leu substitution of the Shufﬂe an-
alog (PenShufLeu) exhibiting a reduced viability and similar or
increased antimicrobial activity.
Earlier investigations on the antibacterial activity of penetratin
against S. aureus reports MIC values ranging from 1 μM (KCTC 1621)
[36] to >100 μM (ATCC 25923) [37]. The inconsistency of theseTable 2
Cytotoxicity and antibacterial activity of an array of CPPs.
Peptide Viabilitya
[μM]
Hemolysisb
[μM]
MICc [μM]/TI
S. aureus
MICc [μM]/TI
E. coli
Penetratin 281±56.5 >128 64/4.4 32/8.8
PenArg 36±3.6 >128 16/2.3 8/4.5
PenLys >1000 >128 256/>3.9 64/>15.6
PenLeu >1000 >128 64/>15.6 32/31.3
Pen13 >1000 >128 256/>3.9 128/>7.8
Pen13Arg 36±5.7 >128 32/1.1 32/1.1
Pen13Lys >1000 >128 256/>3.9 256/>3.9
Pen10 >1000 – >256/– >256/>3.9
PenShuf 17±1.2 >128 64/0.3 32/0.5
PenShufLeu 9±0.9 65±2.5 16/0.6 32/0.3
PenShufLysLeu 33±8.5 91±2.3 32/1.0 32/1.0
PenShufArgLeu 5±0.2 39±1.4 16/0.3 16/0.3
WR8 442±66.7 >128 44/10.1 44/10.1
Tat13 849±77.8 – >256/b3.3 256/3.3
a (n=3; mean±SD) required to attain 50% viability in HeLa WT cells after 1 h of in-
cubation determined by the MTS/PMS assay.
b Hemolysis was determined as the peptide concentration in μM (n=2; mean±SD)
necessary to lyse 50% of the erythrocytes in a sample of fresh human blood after 1 h of
incubation.
c The minimal inhibitory concentration (MIC) of the peptides were determined in
μM (n=3) for S. aureus (ATCC 33591) as well as E. coli (ATCC 25922) and the therapeu-
tic index (TI) is listed as the viability/MIC.reports leaves little opportunity for comparison although the current
ﬁnding of a MIC of 64 μM is within this range. The MIC of penetratin
towards E. coli was earlier reported by Palm and colleagues to be
25 μM (K12) [57], which is in good accordance with the 32 μM
found in the present study, while MIC values as low as 2 μM (KCTC
1682) in a low nutrition 1% (w/v) peptone solution has been reported
[37].
Although the observed antimicrobial activity of AMPs generally
increases with a higher Arg content, the therapeutic index is usually
less favorable, due to a signiﬁcantly lowered cell viability [58]. Thus,
the opposite trend was seen for PenLys corroborating the correlation
between the inﬂuence of cationic residues on both antibacterial activ-
ity and cytotoxicity. The truncated analogs exhibited decreased
antibacterial activity as compared to the full-length analogs. Only
the all-Arg variant of the 13-mer penetratin analog (Pen13Arg)
possessed activity comparable to the full-length analogs albeit with
a concomitant decrease in eukaryotic cell viability.
3.4. Peptide-membrane interactions
The POPC:POPG:cholesterol (molar ratio 5:3:2) liposomes had an
average size of 98 nm (PDI 0.114) and 65 nm (PDI 0.055) for the
empty and calcein-loaded vesicles, respectively. The POPC:POPG
(molar ratio 3:7) liposomes showed an average size of 90 nm (PDI
0.113) and 56 nm (PDI 0.078) for the empty and calcein-loaded
vesicles, respectively. By CD spectroscopy it was inferred that all
full-length penetratin analogs, including the shufﬂed variants, as-
sumed α-helical conformations while interacting with cholesterol-
containing liposomes consisting of POPC:POPG:cholesterol (molar
ratio 5:3:2) (Fig. 3; solid line), whereas no secondary structure was
apparent in buffer solution (data not shown). Only minor differences
in the secondary structure of Pen, PenArg and (to some extent)
PenLys were observed in the presence of the cholesterol-containing
liposomes POPC:POPG:cholesterol (molar ratio 5:3:2), as well as in
the presence of the highly anionic liposomes POPC:POPG (molar
ratio 3:7), conﬁrming previous reports [38]. Similarly, the series of
shufﬂed analogs exhibited unstructured conformations in buffer,
however, the presence of the cholesterol-containing and the highly
anionic liposomes both induced pronounced conformational changes
as compared to the non-shufﬂed full length penetratin analogs
(Fig. 3; dashed line). Thus, the shufﬂed analogs displayed a character-
istic minimum at 222 nm when interacting with the cholesterol-
containing liposomes, but lacked the minimum around 208 nm when
Fig. 3. Circular dichroism spectroscopy of penetratin and analogs in the presence of POPC:POPG:cholesterol (molar ratio 5:3:2) liposomes: solid line; POPC:POPG (molar ratio 3:7)
liposomes: dashed line. a) Penetratin, b) PenArg, c) PenLys, d) PenShuf, e) PenShufArgLeu, and f) PenShufLysLeu. The measurements were performed with a lipid concentration of
2 mM and a peptide concentration of 20 μM, resulting in a lipid to peptide molar ratio of 100:1.
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no detectable secondary structure neither in buffer nor in the presence
of lipid model membranes (data not shown). These ﬁndings further
corroborate previous ﬁndings that penetratin exposed to an apolar
environment, mainly exist in an α-helical conformation [59].Fig. 4. Helical wheel projection of penetratin (left) and shufﬂe (righRelease of dye from calcein-loaded liposomes with the same lipid
compositions as those used for CD spectroscopy was conducted, and
no signiﬁcant calcein release was observed for liposomes exposed to
penetratin in concentrations up to 500 μM. None of the tested pep-
tides caused calcein leakage at molar concentrations similar tot). Black: basic; gray: polar, uncharged; and unﬁlled: nonpolar.
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cating the absence of signiﬁcant membrane disruption. This is in ac-
cordance with earlier investigations of dye leakage from unilamellar
vesicles interacting with penetratin [9,32,36,60,61], or with PenLys
and PenArg [9] for which only low or no leakage was found.
To visualize the spatial display of amino acid side chain orientation
in the peptides, idealized as perfect α-helices, the corresponding he-
lical wheel projections were examined (Fig. 4). Penetratin and
PenShuf display only limited amphipathic character, i.e. the FWI
side chain patch (unﬁlled) in penetratin, and the two WI residues
(unﬁlled) on the same side of the helix of the shufﬂed analog consti-
tute the largest hydrophobic patches, while the larger polar/cationic
RKKQR patch (black and gray) is present in both peptides.
4. Discussion
Several investigations of the all-Arg and all-Lys penetratin variants
(here denoted PenArg and PenLys, respectively) have been reported,
ranging from biophysical characterization in various model systems
[9,38] over in vitro characterization [34,39] to in vivo assays [40].
Thus, it has been demonstrated that a high content of Arg in CPPs
results in increased uptake into eukaryotic cells, most likely due to
an improved interaction of the peptide with membranes [33,40].
Our results from uptake experiments performed on HeLa WT cells
show that all ﬂuorophore-labeled CPPs examined gave rise to some
degree of uptake under the applied conditions. The only CPP taken
up to a higher degree than native penetratin was PenArg, emphasiz-
ing the fact that the initial guanidinium-membrane phospholipid
interaction is superior in promoting peptide internalization in
eukaryotic cells. This point was further substantiated by the signiﬁ-
cantly lower uptake of PenLys as compared to native penetratin.
The eukaryotic cell viability following exposure to the non-labeled
peptides correlated with the efﬁciency of internalization. The cell vi-
ability EC50 value attained upon incubation of the cells with CPP
was almost eight times lower for PenArg than for penetratin, but at
least 3.5 times higher for PenLys as compared to penetratin. This
expected tendency of Arg-promoted uptake and increased cytotoxic-
ity was observed for the truncated series as well. Fischer et al. [33]
reported the effect of truncation of the 16-mer penetratin, and it
was found that truncation severely diminished the in vitro cellular
peptide uptake. While the N-terminal part of the peptide was almost
inactive, partial activity was retained for shorter sequences con-
taining an intact C-terminal part. Khafagy and colleagues [40] have
reported on shufﬂed analogs of penetratin some of which displayed
ﬁxed Arg and Lys residues while the remaining residues were ran-
domly distributed. Earlier reports have shown that PenShuf is capable
of delivering insulin more efﬁciently than native penetratin while
co-administered in vivo [35,40]. These observations seem not to be
directly related to the cellular CPP uptake as we found a signiﬁcantly
lower uptake into HeLa WT cells of CF-labeled PenShuf as compared
to CF-labeled native penetratin. This suggests that the effectiveness
of PenShuf as a drug carrier may not be correlated directly with the
cell-penetrating ability of the peptide itself. The Met→Leu variants
of the all-Arg and all-Lys shufﬂed peptides both exhibited a lower up-
take than the original shufﬂed analog, with no apparent dependency
on the Arg content. This indicates that a high Arg content alone is not
sufﬁcient to ensure internalization, and it thus appears that differ-
ences in the presentation of the cationic residues to the surrounding
microenvironment may be of signiﬁcant importance.
The punctuate uptake pattern of the investigated penetratin
analogs suggests that the compounds have a high local concentration
within distinct compartments of the cells explained by a vesicular
uptake e.g. by endocytosis. This is in line with earlier reports on the
intracellular routing of penetratin [14,62]. The co-localization of the
tested CPPs with the lysosomal tracker further indicates an endocy-
totic uptake pathway as the peptide-containing late endosomeseventually fuse with the lysosomes. This poses a challenge in relation
to the use of the analogs as drug delivery vectors, since delivery into
lysosomes and possible separation from the target would be disad-
vantageous. However, the combination of intracellular uptake and
antimicrobial activity might well be utilized for targeting internalized
bacteria. Thus, S. aureus can be localized within the vacuolar appara-
tus [63], and therefore the transport of AMPs to the vacuolarized
bacteria could be advantageous for S. aureus eradication. Antimicrobi-
al activity of all tested full-length penetratin analogs as well as trun-
cated sequences was most pronounced against the Gram-negative E.
coli, while the PenShuf series exerted similar potency against both E.
coli and S. aureus. Though the antimicrobial activities of PenShuf and
penetratin were comparable, we found a ~16-fold lower HeLa cell
viability upon exposure to PenShuf as compared to exposure to
penetratin. Interestingly, the cytotoxicity and antimicrobial activity
of PenShufLeu indicate that this modiﬁcation had the reverse effect
as compared to that seen for PenLeu where a decrease in cytotoxicity
was observed. Even though Met may be replaced by Leu without
activity loss in native penetratin, the change in side chain geometry
may alter the peptide-membrane interactions of another peptide
altogether and this may be the case for PenShuf [64]. Mishra and
colleagues [65] have shown that the addition of merely a single
hydrophobic residue to an Arg-rich peptide, can markedly alter the
effect of the peptide. The increased antimicrobial as well as cytotoxic
effects of PenShufLeu over PenShuf could therefore be a result of the
somewhat higher hydrophobicity of the Leu residue over Met, leading
to an increased stabilization of transmembrane pores. However, the
same substitution in native penetratin (PenLeu) did not alter the an-
timicrobial, cell-penetrating or cytotoxic activities of the peptide
supporting the ﬁnding that charge and hydrophobicity alone cannot
account for all the observed activities.
Signiﬁcant conformational changes were observed for the shufﬂed
analogs when these were allowed to interact with cholesterol-
containing liposomes and highly anionic liposomes. Similar changes
were not seen for the full-length analogs of native penetratin, indicat-
ing differences in the resulting secondary structures of these subtypes
of penetratin analogs while interacting with model lipid membranes.
This may also simply reﬂect a less favorable membrane interaction of
the shufﬂed analogs resulting in a signiﬁcant contribution to the CD
signal from an unstructured subpopulation of the peptide molecules.
However, the latter explanation appears less likely as it is not
reﬂected by the antibacterial effect of the shufﬂed analogs. In fact,
cytotoxicity, hemolysis as well as antimicrobial activity data support
a stronger interaction of the shufﬂed analogs with both mammalian
and bacterial membranes as compared to the other investigated
peptides.
The results from the calcein release assay suggest that no signiﬁ-
cant membrane perturbation occurs during exposure to the investi-
gated peptides. This is further substantiated by the lack of
amphipathicity as indicated by simple helical wheel projections of
penetratin and PenShuf (Fig. 4) [66]. Based on the present CD spectro-
scopic studies, supporting earlier reports, penetratin obviously
possesses a high degree of α-helicity while interacting with
cholesterol-containing phospholipid liposomes similar to those ap-
plied in the present study [9,38,67].
5. Conclusion
In summary, in the present investigation we have determined
the membrane activity of a variety of different analogs of penetratin
that readily could be ranked with respect to both eukaryotic cell up-
take, antimicrobial activity against both Gram-positive and Gram-
negative bacteria as well as hemolysis and eukaryotic cell viability
upon exposure to the peptides. It has been shown that the content
of Arg in these peptides is of imperative importance, as the presence
of multiple guanidinium groups both facilitates uptake and enhances
231J.S. Bahnsen et al. / Biochimica et Biophysica Acta 1828 (2013) 223–232antimicrobial activity, though at the penalty of higher cytotoxicity as
indicated by hemolytic properties and lowered HeLa cell viability.
Nevertheless, not only the cationic amino acid composition of the
peptides was shown to be important, but also the sequence of the
non-basic amino acids as well as the peptide conformation had a
substantial impact on the effect of single-residue substitutions. As
such, the PenShuf sequence showed signiﬁcantly different character-
istics as compared to native penetratin, and a single amino acid sub-
stitution of Met to Leu was found to give rise to substantial changes
in the antibacterial, cell-penetrating and cytotoxic effects of PenShuf,
while the same substitution in native penetratin had no effect. The
effectiveness of some of the investigated peptides to cross mammali-
an membranes combined with their ability to kill bacteria, indicate
that further structural optimization might allow for future develop-
ment of antimicrobial CPPs targeting internalized bacteria.Acknowledgements
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